Fingerprint
Dive into the research topics of 'Rucaparib in ovarian cancer: Extending the use of PARP inhibitors in the recurrent disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rucaparib in ovarian cancer: Extending the use of PARP inhibitors in the recurrent disease
Graziela Z. Dal Molin, Shannon N. Westin, Robert L. Coleman
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations